Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy

Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy

Currently, ketamine is the only legal psychedelic medicine available to mental health providers for the treatment of emotional suffering. Over the past several years, ketamine has come into psychiatric use as an intervention for treatment resistant depression (TRD), administered intravenously withou...

Full description

Saved in:
Bibliographic Details
Published in:Journal of psychoactive drugs Vol. 51; no. 2; pp. 189 - 198
Main Authors: Dore, Jennifer, Turnipseed, Brent, Dwyer, Shannon, Turnipseed, Andrea, Andries, Julane, Ascani, German, Monnette, Celeste, Huidekoper, Angela, Strauss, Nicole, Wolfson, Phil
Format: Journal Article
Language:English
Published: United States Taylor & Francis 01-04-2019
Haight Ashbury Publications
Subjects:
Adult
Anxiety - therapy
Clinical outcomes
Combined Modality Therapy
Demographics
Depression
Depression - therapy
Drug therapy
Female
Hallucinogens - administration & dosage
Humans
Ketamine
Ketamine - administration & dosage
Male
Mental depression
psychedelic psychotherapy
psychedelics
Psychotherapy
Psychotherapy - methods
Psychotropic drugs
PTSD
Retrospective Studies
PTSD
psychedelics
Depression
psychotherapy
ketamine
psychedelic psychotherapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Currently, ketamine is the only legal psychedelic medicine available to mental health providers for the treatment of emotional suffering. Over the past several years, ketamine has come into psychiatric use as an intervention for treatment resistant depression (TRD), administered intravenously without a psychotherapeutic component. In these settings, ketamine's psychedelic effects are viewed as undesirable "side effects." In contrast, we believe ketamine can benefit patients with a wide variety of diagnoses when administered with psychotherapy and using its psychedelic properties without need for intravenous (IV) access. Its proven safety over decades of use makes it ideal for office and supervised at-home use. The unique experience that ketamine facilitates with its biological, experiential, and psychological impacts has been tailored to optimize office-based treatment evolving into a method that we call Ketamine Assisted Psychotherapy (KAP). This article is the first to explore KAP within an analytical framework examining three distinct practices that use similar methods. Here, we present demographic and outcome data from 235 patients. Our findings suggest that KAP is an effective method for decreasing depression and anxiety in a private practice setting, especially for older patients and those with severe symptom burden.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0279-1072
2159-9777
DOI:10.1080/02791072.2019.1587556